General Practice Doctors in Niles, MI Accepting Medicare

4 General Practice doctors found. Showing 1 - 4

Dr. Helene M Johnson, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 42 N Saint Joseph Ave, Suite 200, Niles, MI 49120 Phone: 269-687-0808    Fax: 269-687-0811

Brandon Smeltzer, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 45 Longmeadow Ln, Niles, MI 49120 Phone: 734-845-8216

Ronald L Kissel, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 423 Sycamore St Ste 103, Niles, MI 49120 Phone: 269-479-3030    Fax: 269-479-3032

Norbert Schwer, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 423 Sycamore St Ste 103, Niles, MI 49120 Phone: 269-479-3030    Fax: 269-479-3032

News Archive

Watson Laboratories receives FDA approval for Amlodipine capsules

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate/Benazepril 5/20mg, 10/20mg, 2.5/10mg, and 5/10mg capsules, the generic equivalent to Novartis' Lotrel capsules.

Study: High-protein diet increases chance of developing kidney stones and other renal diseases

An experiment by scientists at the University of Granada, Spain, shows a high-protein diet increases the chance of developing kidney stones and other renal diseases.

3T MRI detects significant number of lesions not found on mammography and sonography

3T MRI, a powerful tool for evaluating patients with a high risk of having breast cancer, can detect a significant number of lesions not found on mammography and sonography, according to a study performed at the University of Toledo Medical Center, Toledo, OH.

Study finds multiple gaps in rural opioid crisis research

Rural areas have been hit hard by the opioid crisis, but few studies have been done to understand how to improve access to treatment and reduce the overdose death rate in these communities, according to a new study by Rutgers University, the University of Michigan, and Wayne State University.

IDC secures $32 million in Series B financing

Immune Design Corp. (IDC), a privately held biotechnology company focused on developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has secured $32 million in Series B financing. The round was led by ProQuest Investments and was joined by current investors: The Column Group, Versant Ventures, and Alta Partners. The Series B financing brings the total amount of equity capital raised by IDC to $50 million since its inception in 2008.

Read more Medical News

› Verified 9 days ago